Stock Track | EDGE MEDICAL-B Soars 6.74% Intraday on Improved Financial Results with Narrower Loss and Revenue Surge

Stock Track03-30

EDGE MEDICAL-B's stock soared 6.74% during intraday trading on Monday, reflecting strong investor sentiment.

The surge follows the company's release of its 2025 financial results, which showed a significant improvement in performance. Shenzhen Edge Medical reported a narrower attributable loss of 88.6 million yuan for 2025, compared to a loss of 218.5 million yuan in the prior year. Concurrently, the company's revenue nearly tripled, surging 185% to 455.7 million yuan.

This substantial revenue growth and reduced loss demonstrate positive operational momentum, which likely fueled the buying interest and drove the stock price higher in the session.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment